News

Published on 23 Jun 2021 on Simply Wall St. via Yahoo Finance

Could The 9 Meters Biopharma, Inc. (NASDAQ:NMTR) Ownership Structure Tell Us Something Useful?


Article preview image

If you want to know who really controls 9 Meters Biopharma, Inc. (NASDAQ:NMTR), then you'll have to look at the makeup of its share registry. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. Companies that used to be publicly owned tend to have lower insider ownership.

9 Meters Biopharma is a smaller company with a market capitalization of US$352m, so it may still be flying under the radar of many institutional investors. Our analysis of the ownership of the company, below, shows that institutional investors have bought into the company. We can zoom in on the different ownership groups, to learn more about 9 Meters Biopharma.

View our latest analysis for 9 Meters Biopharma

NASDAQ.NMTR price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Nasdaq Gains Over 100 Points; Lockheed Martin Profit Tops Expectations By Benzinga

Nasdaq Gains Over 100 Points; Lockheed Martin Profit Tops Expectations

Investing.com 18 Jul 2023

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.06% By Investing.com

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.06%

Investing.com 18 Jul 2023

Why Are 9 Meters Biopharma Shares Nosediving Today?

9 Meters Biopharma IncĀ (NASDAQ: NMTR) shares plummeted after the company filed for Chapter 11 ban...

Benzinga via Yahoo Finance 18 Jul 2023

8 Best Penny Stocks To Buy Under $1.00

Penny stocks are often found in emerging industries or in industries that require a long period o...

GoBankingRates via AOL 18 Jan 2023

Why Akouos Shares Are Trading Sharply Higher? Here Are 36 Stocks Moving In Tuesday's Mid-Day Session...

Why Akouos Shares Are Trading Sharply Higher? Here Are 36 Stocks Moving In Tuesday's Mid-Day Sess...

Investing.com 18 Oct 2022

9 Meters (NMTR) Up on Results From Bowel Syndrome Candidate

9 Meters Biopharma NMTR was up 31.7% pre-market on Sep 27, after the company announced top-line r...

Zacks via Yahoo Finance 28 Sep 2022

Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket By Benzinga

Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket

Investing.com 28 Sep 2022

NMTR stock gains after mid-stage data for short bowel syndrome drug (NASDAQ:NMTR)

9 Meters Biopharma, Inc. (NMTR), a company focused on rare digestive diseases, added ~24% pre-mar...

Seeking Alpha 27 Sep 2022

9 Meters Biopharma Shares Move Higher After Successful Short Bowel Syndrome Study

9 Meters Biopharma IncĀ (NASDAQ: NMTR) announced the final results from the Phase 2 VIBRANT study ...

Benzinga via Yahoo Finance 27 Sep 2022

10 Best Penny Stocks to Buy in September

In this article, we discuss 10 best penny stocks to buy in September. If you want to see more sto...

Insider Monkey via Yahoo Finance 8 Sep 2022